Ovarian cysts and cyclic hormone replacement therapy: is there an association?

Authors

  • Itai Bar-Hava,

    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author
  • Raoul Orvieto,

    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author
  • David Vardimon,

    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author
  • Yoram Manor,

    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author
  • Ariel Weissman,

    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author
  • Roni Nelinger,

    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author
  • Zion Ben-Rafael

    Corresponding author
    1. Department of Obstetrics and Gynecology, Rabin Medical Center (Golda Campus), Petah-Tiqva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for more papers by this author

Department of Obstetrics and Gynecology Rabin Medical Center (Golda Campus), Petah-Tiqva, 49372, Israel

Abstract

Objectives. To evaluate whether there may be an association between postmenopausal ovarian cysts and hormone replacement therapy.

Methods. The study comprised 564 consecutive, asymptomatic, postmenopausal women who were referred for routine, transvaginal ultrasound examinations between January 1 and December 31, 1995. Various demographic and ultrasonographic parameters were recorded on a prospectively-created, computerized data base.

Results. There was no difference in the prevalence of ovarian cysts with or without hormone replacement therapy (10.5% vs. 12.5%, respectively). However, in the subgroup of early postmenopausal women (40-55 years), the use of hormone replacement therapy was associated with a significantly reduced prevalence of ovarian cysts (10.4% vs. 28.6%; p<0.05). Conclusions. Hormone replacement therapy is associated with a reduced prevalence of ovarian cysts in early postmenopause.

Ancillary